AN ACT to provide for a legislative management study regarding prescription drug pricing and the maximum fair price as determined by the federal government.

HB 1543 authorizes a legislative study to examine federal prescription drug pricing mechanisms, specifically the maximum fair price set by the U.S. Department of Health and Human Services under the Inflation Reduction Act. The study will analyze how federal drug pricing negotiations overlap with drugs covered by North Dakota's public employees retirement system to assess potential cost savings for the state and consumers. It requires input from the public employees retirement system, insurance commissioner, state pharmacy board, and other stakeholders. The legislative management must report findings and any recommended legislation to the next state legislative assembly.